Clinical trials
4 active studies led by Tenaya Therapeutics, of 4 in all
Source: ClinicalTrials.gov, Studies with Tenaya Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Tenaya Therapeutics in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Tenaya Therapeutics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Source: SEC EDGAR, Company filings, CIK 1858848. Retrieved 13 Nov 2026.
4 active studies led by Tenaya Therapeutics, of 4 in all
Source: ClinicalTrials.gov, Studies with Tenaya Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1858848.
Studies Tenaya Therapeutics leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Tenaya Therapeutics or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Tenaya Therapeutics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Tenaya Therapeutics is in.